Oxygen sensing by HIF hydroxylases
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under well-oxygenated conditions HIFα becomes hydroxylated at one (or both) of two highly conserved prolyl residues located near the NTAD by members of the prolyl hydroxylase domain (PHD) family (also called EgIN family or HPH family) (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“When oxygen is available, FIH1 hydroxylates a conserved asparaginyl residue within the HIF1α and HIF2α CTADs, leading to a steric clash that prevents the recruitment of the coactivators p300 and CBP (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“Ascorbate is required for full catalytic activity and likely functions to reduce the catalytic iron in the event of uncoupled turnover, in which failure to oxidize the HIFα substrate leaves the iron center in an oxidized and inactive form (Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“This hydroxylation is mediated by prolyl-4-hydroxylases (PHDs), a set of oxygen-, iron-, and ascorbatedependent enzymes belonging to the 2-oxoglutarate-dependent oxygenase superfamily (Schofield & Ratcliffe, 2004).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Schofield & Ratcliffe, 2004
In the citing paper
“From a mechanistic standpoint, HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem like properties [20,250,251].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [250]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“For example, defects in the genes that encode the succinate dehydrogenase subunits B, C and”
Background
Cited by
Items 1,001–1,005 of 1,005
Transcription factors and cognate signalling cascades in the regulation of autophagy
Chandra, V., Bhagyaraj, E., Parkesh, R., & Gupta, P. (2016) · Biological Reviews · doi:10.1111/brv.12177 · Cited by 26
“(8) Hypoxia-inducible factor-1 (HIF-1) HIF-1 is an oxygen-dependent transcription factor that primarily ensures cell survival under hypoxic conditions until normal oxygen levels are restored (Schofield & Ratcliffe, 2004).”
BackgroundMatot, I., Nachmansson, N., Duev, O., Schulz, S., Schroeder‐Stein, K., Frede, S., & Abramovitch, R. (2017) · The FASEB Journal · doi:10.1096/fj.201700153r · Cited by 24
Solomon, T., Lapek, J. D., Jensen, S. B., Greenwald, W. W., Hindberg, K., Matsui, H., Latysheva, N., Braekken, S. K., Gonzalez, D. J., Frazer, K. A., et al. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.118.002170 · Cited by 22
Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
HIF inhibition: Current strategies and clinical challenges
Więch-Walów, A., Bartoszewska, S., Barton, A., Czechowicz, P., Dudzik, J., Wielockx, B., Collawn, J. F., & Bartoszewski, R. (2026) · Redox biology · doi:10.1016/j.redox.2026.104220 · Cited by 3
“From a mechanistic standpoint, HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem like properties [20,250,251].”
Metadata
- Authors
- Schofield, C. J., & Ratcliffe, P. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Ratcliffe, Peter J.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2004-05
- Volume
- 5
- Issue
- 5
- Pages
- 343-354
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1991346678
- Semantic Scholar
- 17237b87d7ea79ae6e18c24d4de83bfeffbd7c2e
- Cited by
- 2,068
- References
- 109
- Citations by year
- 2026: 62 · 2025: 55 · 2024: 92 · 2023: 90 · 2022: 121 · 2021: 95 · 2020: 106 · 2019: 80 · 2018: 95 · 2017: 91 · 2016: 106 · 2015: 99 · 2014: 120 · 2013: 83 · 2012: 76
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Medical Research Council
- Biotechnology and Biological Sciences Research Council (B18672, BBS/B/07683)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, oxygen sensing, 2-oxoglutarate-dependent dioxygenase, oxygen homeostasis, transcriptional regulation, molecular oxygen
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Hydroxylation, Ketoglutaric Acids, Oxygen, Oxygenases, Transcription Factors, Cell Hypoxia, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.